Otrivin 0.1% 10 ml nasal spray metered
- $5.40
The instruction
for medical use
of OTRIVIN® medicine
the Trade name
of Otrivin®
the International unlicensed
name Xylomethazolinum Dosage Form Spray the nasal
Structure
of 1 ml of solution dosed 0.1% contains
active agent: xylomethazolinum hydrochloride of 1 mg
excipients: sodium dihydrophosphate a dihydrate, sodium hydrofosfat dodecahydrate, sodium chloride, a benzalkoniya chloride, disodium EDTA salt, methylhydroxypropyl cellulose 4000, sorbitol solution of 70%, the water purified.
The description
Transparent colourless solution almost flavourless
Pharmacotherapeutic group
of Antikogestanta and other nasal drugs for topical administration.
Sympathomimetics. Xylomethazolinum.
The ATX R01AA07 code
Pharmacological properties
Ksilometazolin belongs to group of local vasoconstrictors (decongestants) with a-adrenomimeticheskim action, causes narrowing of blood vessels mucous a nose, eliminating, thus, hypostasis and hyperaemia of a mucous membrane of a nasopharynx. Facilitates nasal breath in rhinitises.
In therapeutic concentration does not irritate mucous, does not cause hyperaemia. Action comes in a few minutes and continues within several hours.
Indications
- acute respiratory diseases with the phenomena of rhinitis (cold)
- acute allergic rhinitis
- a pollinosis
- sinusitis
- an eustachitis
- average otitis (for reduction of hypostasis of a mucous nasopharynx)
- training of the patient for diagnostic manipulations in the nasal courses.
Route of administration and
Intranazalno's doses.
Adults and children are more senior than 12 years: On 1 injection in each nasal course with an interval of 8-10 hours.
It is not necessary to use drug more than 3 times a day and also it is not necessary to apply more than 10 days.
Side effects
Often:
- a headache
- irritation and/or dryness of a mucous membrane of a nasopharynx, burning, sneezing, hypersecretion
Seldom
- reactions of hypersensitivity (Quincke's edema, urticaria, an itching)
- a rhinedema
- a disorder of vision
- heartbeat, tachycardia, arrhythmias, increase in arterial blood pressure
- nausea
- insomnia
- a depression (at prolonged use of high doses)
Contraindications
- hypersensitivity to xylomethazolinum or any other component of drug
- arterial hypertension
- tachycardia
- the profound atherosclerosis
- glaucoma
- atrophic rhinitis
- a hyperthyroidism
- surgical interventions on a meninx (in the anamnesis)
- children's age up to 12 years
- pregnancy and the period of a lactation
With care – in diabetes.
Medicinal interactions
It is incompatible with MAO inhibitors and tricyclic antidepressants
the Special
instructions Otrivin®, as well as other sympathomimetic means, it is necessary to appoint with care to patients at whom at use of adrenergic drugs, the strong reactions which are expressed as insomnia, dizziness, a tremor, disturbance of a warm rhythm or increase in arterial blood pressure are noted.
Drug should not be used for a long time, for example, in chronic rhinitis. Long-term treatment by drug can cause converse effect.
It is not necessary to exceed the recommended drug doses, especially at treatment of children and elderly people.
There are no sufficient data on action of Otrivina® on fertility. As system influence of xylomethazolinum of a hydrochloride is very low, its influence on fertility is improbable.
Features of influence of medicine on ability to run the vehicle or potentially dangerous
Otrivin® mechanisms in the dosages exceeding recommended can influence ability to run the vehicle or potentially dangerous mechanisms.
Overdose
Symptoms: strengthening of side effects, confusion of consciousness.
Treatment is symptomatic.
A form of release and packing
On 10 ml of drug in the bottle from polyvinylpirrolidone supplied with the pompovy portioning device with a tip and with a protective cap from polyethylene.
On 1 bottle together with the instruction for use in the state and Russian languages put in a pack from cardboard.
To Store storage conditions at a temperature not above 30 °C.
To store out of children's reach!
A period of storage
3 years
not to use drug after expiry date.
Prescription status
Without prescription
the Name and the country
of the Novartis Konsyyumer Hels SA manufacturing organization, Switzerland
the Name and the country of the owner of the registration certificate
of Novartis Konsyyumer Hels SA, Switzerland
the Name and the country
of the Novartis Konsyyumer Hels SA organization packer, Switzerland
the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from the consumer on quality
of the Novartis Pharm Services AG Branch product in RK
Almaty, Luganskogo St., 96
ph. 8-800-080-0650 (free from all stationary phones across the Republic of Kazakhstan)
fax: (727) 258-33-03
e-mail: consumerhealth.cis@novartis.com
for medical use
of OTRIVIN® medicine
the Trade name
of Otrivin®
the International unlicensed
name Xylomethazolinum Dosage Form Spray the nasal
Structure
of 1 ml of solution dosed 0.1% contains
active agent: xylomethazolinum hydrochloride of 1 mg
excipients: sodium dihydrophosphate a dihydrate, sodium hydrofosfat dodecahydrate, sodium chloride, a benzalkoniya chloride, disodium EDTA salt, methylhydroxypropyl cellulose 4000, sorbitol solution of 70%, the water purified.
The description
Transparent colourless solution almost flavourless
Pharmacotherapeutic group
of Antikogestanta and other nasal drugs for topical administration.
Sympathomimetics. Xylomethazolinum.
The ATX R01AA07 code
Pharmacological properties
Ksilometazolin belongs to group of local vasoconstrictors (decongestants) with a-adrenomimeticheskim action, causes narrowing of blood vessels mucous a nose, eliminating, thus, hypostasis and hyperaemia of a mucous membrane of a nasopharynx. Facilitates nasal breath in rhinitises.
In therapeutic concentration does not irritate mucous, does not cause hyperaemia. Action comes in a few minutes and continues within several hours.
Indications
- acute respiratory diseases with the phenomena of rhinitis (cold)
- acute allergic rhinitis
- a pollinosis
- sinusitis
- an eustachitis
- average otitis (for reduction of hypostasis of a mucous nasopharynx)
- training of the patient for diagnostic manipulations in the nasal courses.
Route of administration and
Intranazalno's doses.
Adults and children are more senior than 12 years: On 1 injection in each nasal course with an interval of 8-10 hours.
It is not necessary to use drug more than 3 times a day and also it is not necessary to apply more than 10 days.
Side effects
Often:
- a headache
- irritation and/or dryness of a mucous membrane of a nasopharynx, burning, sneezing, hypersecretion
Seldom
- reactions of hypersensitivity (Quincke's edema, urticaria, an itching)
- a rhinedema
- a disorder of vision
- heartbeat, tachycardia, arrhythmias, increase in arterial blood pressure
- nausea
- insomnia
- a depression (at prolonged use of high doses)
Contraindications
- hypersensitivity to xylomethazolinum or any other component of drug
- arterial hypertension
- tachycardia
- the profound atherosclerosis
- glaucoma
- atrophic rhinitis
- a hyperthyroidism
- surgical interventions on a meninx (in the anamnesis)
- children's age up to 12 years
- pregnancy and the period of a lactation
With care – in diabetes.
Medicinal interactions
It is incompatible with MAO inhibitors and tricyclic antidepressants
the Special
instructions Otrivin®, as well as other sympathomimetic means, it is necessary to appoint with care to patients at whom at use of adrenergic drugs, the strong reactions which are expressed as insomnia, dizziness, a tremor, disturbance of a warm rhythm or increase in arterial blood pressure are noted.
Drug should not be used for a long time, for example, in chronic rhinitis. Long-term treatment by drug can cause converse effect.
It is not necessary to exceed the recommended drug doses, especially at treatment of children and elderly people.
There are no sufficient data on action of Otrivina® on fertility. As system influence of xylomethazolinum of a hydrochloride is very low, its influence on fertility is improbable.
Features of influence of medicine on ability to run the vehicle or potentially dangerous
Otrivin® mechanisms in the dosages exceeding recommended can influence ability to run the vehicle or potentially dangerous mechanisms.
Overdose
Symptoms: strengthening of side effects, confusion of consciousness.
Treatment is symptomatic.
A form of release and packing
On 10 ml of drug in the bottle from polyvinylpirrolidone supplied with the pompovy portioning device with a tip and with a protective cap from polyethylene.
On 1 bottle together with the instruction for use in the state and Russian languages put in a pack from cardboard.
To Store storage conditions at a temperature not above 30 °C.
To store out of children's reach!
A period of storage
3 years
not to use drug after expiry date.
Prescription status
Without prescription
the Name and the country
of the Novartis Konsyyumer Hels SA manufacturing organization, Switzerland
the Name and the country of the owner of the registration certificate
of Novartis Konsyyumer Hels SA, Switzerland
the Name and the country
of the Novartis Konsyyumer Hels SA organization packer, Switzerland
the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from the consumer on quality
of the Novartis Pharm Services AG Branch product in RK
Almaty, Luganskogo St., 96
ph. 8-800-080-0650 (free from all stationary phones across the Republic of Kazakhstan)
fax: (727) 258-33-03
e-mail: consumerhealth.cis@novartis.com
Related Products
-20%
Recently Viewed
